Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis |
| |
Authors: | Eunjin Lee Ji Eun Oh |
| |
Affiliation: | 1.Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea ; 2.BioMedical Research Center, KAIST, Daejeon 34141, Korea |
| |
Abstract: | It has been more than a year since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged. Many studies have provided insights into the various aspects of the immune response in coronavirus disease 2019 (COVID-19). Especially for antibody treatment and vaccine development, humoral immunity to SARS-CoV-2 has been studied extensively, though there is still much that is unknown and controversial. Here, we introduce key discoveries on the humoral immune responses in COVID-19, including the immune dynamics of antibody responses and correlations with disease severity, neutralizing antibodies and their cross-reactivity, how long the antibody and memory B-cell responses last, aberrant autoreactive antibodies generated in COVID-19 patients, and the efficacy of currently available therapeutic antibodies and vaccines against circulating SARS-CoV-2 variants, and highlight gaps in the current knowledge. |
| |
Keywords: | COVID-19 humoral immunity neutralizing antibody SARS-CoV-2 SARS-CoV-2 variants |
|
|